Cargando…

Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma

We recently introduced CDK5 as target in HCC, regulating DNA damage response. Based on this and on our previous knowledge about vascular effects of CDK5, we investigated the role of CDK5 in angiogenesis in HCC, one of the most vascularized tumors. We put a special focus on the transcription factor H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herzog, Julia, Ehrlich, Sandra M., Pfitzer, Lisa, Liebl, Johanna, Fröhlich, Thomas, Arnold, Georg J., Mikulits, Wolfgang, Haider, Christine, Vollmar, Angelika M., Zahler, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053636/ https://www.ncbi.nlm.nih.gov/pubmed/27027353 http://dx.doi.org/10.18632/oncotarget.8342

Ejemplares similares

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy
por: Ardelt, Maximilian A., et al.
Publicado: (2018)

Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)

Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis
por: Merk, Henriette, et al.
Publicado: (2016)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)
por: Reichl, Patrick, et al.
Publicado: (2016)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Mechanical Aspects of Angiogenesis
por: Kretschmer, Maibritt, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Five Mediates Activation of Lung Xanthine Oxidoreductase in Response to Hypoxia
por: Kim, Bo S., et al.
Publicado: (2015)

Cyclin-dependent kinase 1 disruption inhibits angiogenesis by inducing cell cycle arrest and apoptosis
por: Gao, Xin, et al.
Publicado: (2019)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
por: Holstein, Elisa, et al.
Publicado: (2018)

Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy
por: Pfitzer, Lisa, et al.
Publicado: (2019)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Inhibition of Cdk5 induces cell death of tumor-initiating cells
por: Mandl, Melanie M, et al.
Publicado: (2017)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
por: Miller, Hannah, et al.
Publicado: (2020)

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
por: Xu, Chenzhou, et al.
Publicado: (2018)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
por: Wei, Zhong-liu, et al.
Publicado: (2022)

Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer
por: Moser, Christina, et al.
Publicado: (2017)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Breitenecker, Kristina, et al.
Publicado: (2023)

Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
por: Hedrich, Viola, et al.
Publicado: (2021)

A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding
por: Child, Emma S., et al.
Publicado: (2010)

Spatio-selective activation of nuclear translocation of YAP with light directs invasion of cancer cell spheroids
por: Illes, Bernhard, et al.
Publicado: (2021)

The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death
por: HACIOĞLU*, Betül, et al.
Publicado: (2020)

Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
por: Zhang, Siwei, et al.
Publicado: (2015)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells
por: Zhang, Jianming, et al.
Publicado: (2016)

Actin stabilizing compounds show specific biological effects due to their binding mode
por: Wang, Shuaijun, et al.
Publicado: (2019)

Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
por: Du, Chengli, et al.
Publicado: (2015)

Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
por: Haider, Christine, et al.
Publicado: (2018)

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer
por: Van den Eynden, G G, et al.
Publicado: (2005)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
por: Regel, Ivonne, et al.
Publicado: (2012)

Combined antitumoral effects of pretubulysin and methotrexate
por: Kern, Sarah, et al.
Publicado: (2019)

Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
por: KIM, DO HYUNG, et al.
Publicado: (2014)

Mechano-Signaling Aspects of Hepatocellular Carcinoma
por: Passi, Mehak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7bluuqp3crtn6jor0p9gc8921q